Survival of patients with SLE admitted to an intensive care unit - A retrospective study

Clinical Rheumatology

Volumn 24, Issue 3, 2005, Pages 223-227

  Whitelaw, D A ^a   Gopal, R ^a   Freeman, V ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Flares; Intensive care; Mortality; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE EXACERBATION; ETHNIC GROUP; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LUNG EMBOLISM; NEGRO; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SOUTH AFRICA; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CAUSE OF DEATH; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PATIENT ADMISSION; RETROSPECTIVE STUDIES; SOUTH AFRICA; SURVIVAL RATE;

EID: 20944447519     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1007-3     Document Type: Article

References (26)

1. Klippel JH (1997) Systemic lupus erythematosus: Demographics, prognosis and outcome. J Rheumatol 24 [Suppl 48]:67-71
2. Uramoto KM, Michet CJ, Thumbo J et al (1999) Trends in the incidence and mortality of systemic lupus erythematosus 1950-1992. Arthritis Rheum 42:46-50 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2
3. Ginzler EM, Schorn K (1988) Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 14:67-78 1:STN:280:BieB1M%2FhslQ%3D
4. Gladman DD, Urowitz MB (1987) Morbidity in systemic lupus erythematosus. J Rheumatol 14 [Suppl 13]:223-226 3612650
5. Godeau B, Mortier E, Roy PM et al (1997) Short and long term outcomes for patients with systemic rheumatic diseases admitted to intensive care units: A prognostic study of 181 patients. J Rheumatol 24:1317-1323 1:STN:280:ByiA2s7os1I%3D
6. Ansell SM, Bedhesi S, Ruff B et al (1996) Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 24:981-984 10.1097/00003246-199606000-00018
7. Williams FMK, Chinn S, Hughes GRV, Leach RM (2002) Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 61:414-421 10.1136/ard.61.5.414
8. Studenski S, Allen NB, Caldwell DS et al (1987) Survival in systemic lupus erythematosus. Arthritis Rheum 30:1326-1332 1:STN:280:BieC3svkt1U%3D
9. Paton NIJ, Cheong IKS, Kong NCT et al (1996) Risk factors for infection in Malaysian patients with systemic lupus erythematosus. Q J Med 89:531-538 1:STN:280:BymA3snit1E%3D
10. Cohen MG, Li EK (1992) Mortality in systemic lupus erythematosus: Active disease is the most important factor. Aust N Z J Med 22:5-8 1:STN:280:By2B2Mrms1A%3D
11. Rosner S, Ginzler EM, Diamond HS et al (1982) A multicentre study of outcome in systemic lupus erythematosus. Arthritis Rheum 25:612-617 1:STN:280:Bi2B3s7lsVQ%3D
12. Symmons DPM (1995) Occasional series. Lupus around the world. Frequency of lupus in people of African origin. Lupus 4:176-178 1:STN:280:ByqA1cvhslM%3D
13. Bates WD, Halland AM, Tribe RD et al (1991) Lupus nephritis. Part I. Histopathological classification, activity and chronicity scores. S Afr Med J 79:256-259 1:STN:280:By6C1cfjsF0%3D
14. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 1:STN:280:ByiH28vitFU%3D
15. Whitelaw DA, Spangenberg JJ, Rickman R et al (1999) The association between the antiphospholipid antibody syndrome and neurological impairment in SLE. Lupus 8:444-448 1:STN:280:DyaK1MvhsVartA%3D%3D
16. Raj R, Murin S, Matthay A et al (2002) Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 18:781-803 12418441
17. Nived O, Sturfelt G, Wollheim F (1985) Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group. Q J Med 55:271-287 1:STN:280:BiqB2s7htFA%3D
18. Breshninan B (1989) Outcome and survival in systemic lupus erythematosus. Ann Rheum Dis 48:443-445 2662916
19. Pu SJ, Luo SF, Wu YJJ et al (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96-100 10.1191/ 096120300678828109
20. Staples P, Gerding D, Decker J et al (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17:1-10 1:STN:280:CSuD1cvoslY%3D
21. Duffy KNW, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 18:1180-1184 1:STN:280:By2D2crns1U%3D
22. Jonsson H, Nived O, Sturfelt G (1989) Outcome in systemic lupus erythematosus: A prospective study in a defined population. Medicine 68:141-150 1:STN:280:BiaB3sjovVQ%3D
23. Ter Borg EJ, Horst G, Limburg PC et al (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol 17:1642-1648 2084238
24. Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann N Y Acad Sci 389:406-418 1:STN:280:Bi2B38bktVA%3D
25. Jansen NM, Karnad DP, Guntupalli KK (2002) Rheumatic diseases in the intensive care unit: Epidemiology clinical outcome, management and outcome. Crit Care Clin 18:729-748 12418438
26. Esdaile JM, Abrahamowicz M, Joseph L et al (1996) Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Arthritis Rheum 39:370-378 1:STN:280:BymC1MzlvFM%3D